Patent · US Active

Method of treatment

US11986495B2 · kind B2 · utility

0Cited by

0References

13Claims

0Family size

Assignees

Lions Eye Institute Limited · AU
QIMR Berghofer Medical Research Institute · AU

Inventors

Mariapia A. Degli-Esposti · Perth, AU
Geoffrey R. Hill · New City, US
Christopher E. Andoniou · Woodbridge, AU
Peter Fleming · Fremantle, AU

Key dates

Filing date	Nov 28, 2018
Grant date	May 21, 2024
Priority date	—
Expiry date	Sep 21, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates generally to the inhibition of cytomegalovirus (CMV) reactivation in immunosuppressed subjects, including subjects receiving hematopoietic or solid organ transplants. The present invention is particularly relevant for the treatment of CMV reactivation or infection in subjects with graft-versus-hosts disease (GVHD) or under immunosuppressive therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.